Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: Results of three studies

Connor, Thomas H.; Sessink, Paul J. M.; Harrison, Bruce R.; Pretty, Jack R.; Peters, Byron G.; Alfaro, Raul M.; Bilos, Apple; Beckmann, Gwendolyn; Bing, Michael R.; Anderson, Lakisha M.; DeChristoforo, Robert
March 2005
American Journal of Health-System Pharmacy;3/1/2005, Vol. 62 Issue 5, p475
Academic Journal
Purpose. The results of three studies that describe the external contamination of chemotherapy drug vials are presented. New techniques for the improved decontamination of vials containing cisplatin are also described. Summary. Study 1 evaluated the external contamination of drug vials with cyclophosphamide and ifosfamide in a pharmacy setting. Widespread contamination of the outside of drug vials was found with each drug. Study 2 evaluated the surface contamination of drug vials with cyclophosphamide and fluorouracil in three pharmacies. Sporadic contamination with fluorouracil was detected, while cyclophosphamide was found on most vials. In study 3, investigators compared the decontamination abilities of a standard decontamination procedure at the manufacturer level with an improved decontamination procedure and the use of sleeves to further decrease contamination. Though the methods of each study reported herein differed, the outcomes were similar. All chemotherapy drug vials studied demonstrated levels of contamination with the drug well above the limit of detection. Improved decontamination procedures, combined with the use of protective sleeves, reduced the level of platinum contamination by 90%, suggesting that standard decontamination procedures should be reconsidered. Conclusion. The results of these studies are consistent with several others that have reported contamination of the outside surface of drug vials for a number of chemotherapy drugs. Contamination can be reduced by using decontamination equipment and protective sleeves during the manufacturing process.


Related Articles

  • Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard technique versus a proprietary closed-handling system. Tans, Birgit; Willems, Ludo // Journal of Oncology Pharmacy Practice;Dec2004, Vol. 10 Issue 4, p217 

    Introduction. In 2003 more than 55 000 preparations of injectable hazardous drugs were made in the central admixture service of the University Hospital in Leuven, Belgium. According to the literature, surface contamination occurs, despite the use of special equipment and procedures. The...

  • Drug development times not correlated with drug prices.  // PharmacoEconomics & Outcomes News;4/22/2006, Issue 501, p2 

    Provides information on a retrospective study which analyzed drug development times of 168 human therapeutic drugs. Factors thought to influence drug development time; Median total post-investigation new drug time; Market factors that influenced pricing.

  • Recent changes to FDA-approved labeling.  // American Journal of Health-System Pharmacy;4/15/2005, Vol. 62 Issue 8, p794 

    The article informs about recent changes to the Food & Drug Administration-approved labelling. It informs about bevacizumab injection. A warning was added regarding the higher frequency of cerebral infarction, transient ischemic attack, myocardial infarction, angina, and other arterial...

  • 'Paradoxical pharmacology': therapeutic strategy used by the 'homeopathic pharmacology' for more than two centuries. Teixeira, Marcus Zulian // International Journal of High Dilution Resarch;2014, Vol. 13 Issue 49, p207 

    Using the empirical or phenomenological research method by observing the effects of drugs in the human physiology, Samuel Hahnemann proposed the homeopathic treatment. He synthesized modern pharmacodynamic in the 'primary action' of the drugs and in the consequent and opposite 'secondary action'...

  • Lung Adenocarcinoma Causing Pericardial Tamponade. Yalcinkaya, Serhat; Vural, Ahmet Hakan; �zkan, Hakan // Internet Journal of Thoracic & Cardiovascular Surgery;2003, Vol. 6 Issue 2, p77 

    Pericardial tamponade, a life-threatening emergency, is rarely the first presenting symptom in malignancies. We would like to present the case of a fifty-year old male with an adenocarcinoma of the lung whose pericardial tamponade was the presenting symptom, and who, treated with...

  • Self-Care Strategies to Cope With Taste Changes After Chemotherapy. Rehwaldt, Maureen; Wickham, Rita; Purl, Sandy; Tariman, Joseph; Blendowski, Carol; Shott, Susan; Lappe, Mary // Oncology Nursing Forum;Mar2009, Vol. 36 Issue 2, pE47 

    Purpose/Objectives: To describe factors related to taste changes, to examine patients' use of a self-care suggestion sheet to manage taste changes associated with chemotherapy, and to identify potentially useful strategies for managing specific taste changes after chemotherapy.Design:...

  • New Data Presented at ASCO Show Dose-Dense Chemotherapy Including ELLENCE Extends Survival; A New Sequential Dose-Dense Chemotherapy Regimen Including ELLENCE Significantly...  // Ascribe Newswire: Medicine;6/8/2004, p105 

    New data presented at the 2004 meeting of the American Society of Clinical Oncology suggest that a chemotherapy regimen including ELLENCE may significantly improve survival in breast cancer patients at highest risk of recurrence. Results from the German AGO multi-center Phase III trial show that...

  • High-risk clinical stage I NSGCT: the case for RPLND. Morash, Christopher; Cagiannos, Ilias // World Journal of Urology;Aug2009, Vol. 27 Issue 4, p449 

    High-risk clinical stage I NSGCT patients are at significant risk of harbouring occult metastatic disease. In these patients, treatment options consist of retroperitoneal lymph node dissection (RPLND) or two cycles of primary BEP chemotherapy. Both these options provide a nearly 100% cure rate....

  • Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Genc, Dildar; Canpolat, Cengiz; Berrak, Su // Supportive Care in Cancer;Feb2012, Vol. 20 Issue 2, p385 

    Purpose: The effectiveness of carboplatin and vincristine chemotherapy in the treatment of low-grade glioma (LGG) is well established. However, carboplatin hypersensitivity reactions (CHR) are a major problem leading to premature cessation of therapy. We aimed to investigate the clinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics